Integris Medtech to launch Rs 3,000-crore IPO next week
Integris Medtech is set to launch its initial public offering in late November of this year. The IPO is expected to open on November 27 and close on December 1. The company aims to raise between ₹2,500 and ₹3,000 crore through this offering. Funds...

The issue is expected to open for subscription on November 27 and close on Decemeber 1.
The issue is expected to open for subscription on November 27 and close on Decemeber 1. The company is looking to raise ₹2,500-3,000 crore through the IPO, people familiar with the matter said.
Emails sent to the company and the investment bankers remained unanswered until press time.
Read more: DSP Mutual Fund turns bullish on gold and silver, begins systematic buying
The IPO of the Gurugram-based company will comprise a fresh issue and an offer for sale (OFS). The company plans to use 85% of the net proceeds from the fresh issue to repay or prepay debt at its wholly owned and step-down subsidiaries.
Integris Medtech has a diversified business spanning cardiovascular devices, clinical diagnostics and scientific laboratory solutions. It develops, manufactures, commercialises and sells a wide range of medical devices and laboratory products across international markets.
Read more: Trifecta effect! How RIL, HDFC Bank and ICICI Bank are powering Nifty rebound after 2 years
ICICI Securities, Axis Capital, Citigroup and IIFL Capital Services are the book-running lead managers for the proposed public issue.
Download ET Markets APP